JP7667568B2 - 複素環キナーゼ阻害剤及びその使用 - Google Patents

複素環キナーゼ阻害剤及びその使用 Download PDF

Info

Publication number
JP7667568B2
JP7667568B2 JP2021522057A JP2021522057A JP7667568B2 JP 7667568 B2 JP7667568 B2 JP 7667568B2 JP 2021522057 A JP2021522057 A JP 2021522057A JP 2021522057 A JP2021522057 A JP 2021522057A JP 7667568 B2 JP7667568 B2 JP 7667568B2
Authority
JP
Japan
Prior art keywords
compound
group
alkyl
independently selected
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021522057A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022505645A (ja
JP2022505645A5 (https=
Inventor
ゼーンヘーン，ペーター
マイアー－エヴェルト，セバスチャン
カーンデルワル，ニシテ
バンクロフト，デイヴィッド
Original Assignee
イオックス セラピューティクス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イオックス セラピューティクス アーゲー filed Critical イオックス セラピューティクス アーゲー
Publication of JP2022505645A publication Critical patent/JP2022505645A/ja
Publication of JP2022505645A5 publication Critical patent/JP2022505645A5/ja
Application granted granted Critical
Publication of JP7667568B2 publication Critical patent/JP7667568B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
JP2021522057A 2018-10-23 2019-10-22 複素環キナーゼ阻害剤及びその使用 Active JP7667568B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18202164.2A EP3643713B1 (en) 2018-10-23 2018-10-23 Heterocyclic kinase inhibitors and uses thereof
EP18202164.2 2018-10-23
PCT/EP2019/078751 WO2020083926A1 (en) 2018-10-23 2019-10-22 Heterocyclic kinase inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2022505645A JP2022505645A (ja) 2022-01-14
JP2022505645A5 JP2022505645A5 (https=) 2022-10-31
JP7667568B2 true JP7667568B2 (ja) 2025-04-23

Family

ID=64270595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021522057A Active JP7667568B2 (ja) 2018-10-23 2019-10-22 複素環キナーゼ阻害剤及びその使用

Country Status (13)

Country Link
US (3) US12172993B2 (https=)
EP (2) EP3643713B1 (https=)
JP (1) JP7667568B2 (https=)
KR (1) KR20210081353A (https=)
CN (1) CN112955447B (https=)
AU (1) AU2019368654C1 (https=)
BR (1) BR112021007643A2 (https=)
CA (1) CA3116674A1 (https=)
DK (1) DK3643713T3 (https=)
IL (1) IL282588A (https=)
MX (1) MX2021004568A (https=)
SG (1) SG11202103142TA (https=)
WO (1) WO2020083926A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020051424A1 (en) 2018-09-07 2020-03-12 Pic Therapeutics Eif4e inhibitors and uses thereof
DK3643713T3 (da) 2018-10-23 2025-11-03 Iomx Therapeutics Ag Heterocykliske kinaseinhibitorer og deres anvendelse
TW202146393A (zh) 2020-03-03 2021-12-16 美商皮克醫療公司 Eif4e抑制劑及其用途
EP3901151B1 (en) * 2020-04-21 2026-04-01 iOmx Therapeutics AG Halogenated-heteroaryl and other heterocyclic kinase inhibitors, and uses thereof
CN115398019B (zh) * 2020-08-31 2023-07-07 日本制铁株式会社 钢板及其制造方法
CA3229560A1 (en) 2021-08-25 2023-03-02 Christopher L. Vandeusen Eif4e inhibitors and uses thereof
US12157732B2 (en) 2021-08-25 2024-12-03 PIC Therapeutics, Inc. eIF4E inhibitors and uses thereof
JP2024539268A (ja) * 2021-10-19 2024-10-28 アイオーエムエックス セラピューティクス アーゲー Ｓｉｋ３阻害剤及びその中間体を調製する合成スキーム及び手順
CN116813608B (zh) * 2023-06-08 2024-03-22 英矽智能科技(上海)有限公司 噻唑类化合物及其应用
WO2025229127A1 (en) 2024-04-30 2025-11-06 Iomx Therapeutics Ag A halogenated-heteroaryl kinase inhibitor for treating soft tissue sarcoma and vascular tumors
EP4643861A1 (en) 2024-04-30 2025-11-05 iOmx Therapeutics AG A halogenated-heteroaryl kinase inhbitor for treating soft tissue sarcoma and vascular tumors

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528585A (ja) 2005-01-26 2008-07-31 アイアールエム・リミテッド・ライアビリティ・カンパニー タンパク質キナーゼ阻害剤としての化合物および組成物
JP2020517747A (ja) 2017-04-20 2020-06-18 イオックス セラピューティクス アーゲー 抗腫瘍免疫応答に対する耐性と関連する細胞内キナーゼ、及びその使用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4475916A (en) 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US5374548A (en) 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
MX9203291A (es) 1985-06-26 1992-08-01 Liposome Co Inc Metodo para acoplamiento de liposomas.
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
EP1169038B9 (en) 1999-04-15 2013-07-10 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
US7125875B2 (en) * 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
CA2503715A1 (en) * 2002-10-30 2004-05-21 Merck & Co., Inc. Kinase inhibitors
TWI338004B (en) 2004-02-06 2011-03-01 Bristol Myers Squibb Co Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
ES2377430T3 (es) * 2004-09-02 2012-03-27 Genentech, Inc. Inhibidores piridílicos de la señalización de hedgehog
AU2007296743B2 (en) * 2006-09-11 2012-02-16 Curis, Inc. Tyrosine kinase inhibitors containing a zinc binding moiety
US20090281089A1 (en) * 2008-04-11 2009-11-12 Genentech, Inc. Pyridyl inhibitors of hedgehog signalling
US8907053B2 (en) 2010-06-25 2014-12-09 Aurigene Discovery Technologies Limited Immunosuppression modulating compounds
WO2012040636A2 (en) * 2010-09-24 2012-03-29 The Broad Institute, Inc. Compounds and methods for treating diseases mediated by protease activated receptors
US9255072B2 (en) 2011-03-04 2016-02-09 National Health Rsearch Institutes Pyrazole compounds and thiazole compounds as protein kinases inhibitors
NZ702618A (en) * 2012-06-27 2016-12-23 4Sc Discovery Gmbh Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders
CN106699744B (zh) 2015-11-18 2021-05-11 四川海思科制药有限公司 一种杂环类酰胺衍生物及其制备方法和在药学上的应用
US11274100B2 (en) 2017-06-21 2022-03-15 Daiichi Sankyo Company, Limited EP300/CREBBP inhibitor
DK3643713T3 (da) 2018-10-23 2025-11-03 Iomx Therapeutics Ag Heterocykliske kinaseinhibitorer og deres anvendelse
US20230212163A1 (en) 2020-04-21 2023-07-06 Bayer Aktiengesellschaft 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
JP2024539268A (ja) 2021-10-19 2024-10-28 アイオーエムエックス セラピューティクス アーゲー Ｓｉｋ３阻害剤及びその中間体を調製する合成スキーム及び手順

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528585A (ja) 2005-01-26 2008-07-31 アイアールエム・リミテッド・ライアビリティ・カンパニー タンパク質キナーゼ阻害剤としての化合物および組成物
JP2020517747A (ja) 2017-04-20 2020-06-18 イオックス セラピューティクス アーゲー 抗腫瘍免疫応答に対する耐性と関連する細胞内キナーゼ、及びその使用

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Database REGISTRY，2011年，RN 1340965-30-1, Retrieved from STN international [online] ;retrieved on 04 November 2011
Database REGISTRY，2011年，RN 1340965-51-6, Retrieved from STN international [online] ;retrieved on 04 November 2011
Database REGISTRY，2011年，RN 1351790-75-4, Retrieved from STN international [online] ;retrieved on 23 December 2011
Database REGISTRY，2011年，RN 1351821-70-9, Retrieved from STN international [online] ;retrieved on 23 December 2011
Database REGISTRY，2012年，RN 1358292-34-8, Retrieved from STN international [online] ;retrieved on 29 February 2012
Database REGISTRY，2012年，RN 1358360-60-7, Retrieved from STN international [online] ;retrieved on 29 February 2012
Database REGISTRY，2012年，RN 1358498-08-4, Retrieved from STN international [online] ;retrieved on 29 February 2012
Database REGISTRY，2012年，RN 1359547-85-5, Retrieved from STN international [online] ;retrieved on 02 March 2012

Also Published As

Publication number Publication date
KR20210081353A (ko) 2021-07-01
EP3643713B1 (en) 2025-07-30
DK3643713T3 (da) 2025-11-03
US20210387982A1 (en) 2021-12-16
EP3643713A1 (en) 2020-04-29
WO2020083926A1 (en) 2020-04-30
CN112955447A (zh) 2021-06-11
SG11202103142TA (en) 2021-05-28
AU2019368654A1 (en) 2021-05-06
US20250084076A1 (en) 2025-03-13
EP3870580A1 (en) 2021-09-01
CN112955447B (zh) 2025-09-09
AU2019368654C1 (en) 2025-06-19
CA3116674A1 (en) 2020-04-30
JP2022505645A (ja) 2022-01-14
MX2021004568A (es) 2021-09-08
IL282588A (en) 2021-06-30
BR112021007643A2 (pt) 2021-07-27
US20250101015A1 (en) 2025-03-27
US12172993B2 (en) 2024-12-24
AU2019368654B2 (en) 2025-02-27

Similar Documents

Publication Publication Date Title
JP7667568B2 (ja) 複素環キナーゼ阻害剤及びその使用
CN115667255B (zh) 卤代杂芳基和其他杂环激酶抑制剂及其用途
US12139480B2 (en) 5-thiazolecarboxamide kinase inhibitor and uses thereof
US20230192701A1 (en) Bicyclic kinase inhibitors and uses thereof
TW201534305A (zh) 使用組合療法治療癌症之方法
IL297483A (en) Bifunctional compounds and their uses
US20250199015A1 (en) Cyclin-dependent kinase 2 inhibitors for medical treatment
CN108473472B (zh) 作为p70s6激酶抑制剂的2-氨基喹唑啉衍生物
HK40062784A (en) Halogenated-heteroaryl and other heterocyclic kinase inhibitors, and uses thereof
WO2025059429A1 (en) Modulators of bcl6 for use in a method of treating a cancer or an autoimmune disease
KR20220132538A (ko) 디하이드로오로테이트 데하이드로게나제를 억제하는 방법 및 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221021

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221021

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20231026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231129

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20240110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240112

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240227

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240425

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240523

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240806

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250203

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250305

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250404

R150 Certificate of patent or registration of utility model

Ref document number: 7667568

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150